源于海洋真菌的抗肿瘤天然产物

海洋真菌因其特殊的生存环境和代谢机制而具有产生新型生物活性物质的潜力。近年来随着对海洋微生物研究的深入,从海洋真菌中发现了越来越多的具有抗肿瘤活性且结构新颖的天然产物。这些海洋真菌有的分离自海水、海泥或海洋沉积物,有的来自于海洋生物体。本文综述了近几年来从海洋真菌中分离得到的抗肿瘤天然产物的研究状况。     

海洋真菌代谢产物STb对垂体瘤GH3细胞的毒性作用及其机制探讨

垂体腺瘤是一种严重影响患者生活质量的良性肿瘤,从海洋天然产物筛选具有高效低毒的抗肿瘤药物是目前新药研究的趋势。本实验通过用大鼠垂体瘤GH3细胞系对中山大学化工学院提供的海洋化合物STb（我国南海红树林真菌代谢产物）进行抗垂体瘤活性的筛选,期望能够从海洋天然产物中寻找一种高效的抗垂体瘤药物。     

北部湾海洋植物及其共附生微生物次级代谢产物研究进展(综述)

海洋植物及其共附生微生物是海洋生物的重要组成部分,能够产生许多结构新颖、活性独特的次级代谢产物,承担多种生理生态功能。北部湾海洋植物物种资源丰富,据统计,海洋植物有3门43种。该文综述了从2002年起北部湾海洋植物及其共附生微生物次级代谢产物的研究进展,从11种红树植物和7种共附生微生物中获得59个新化合物和35个已知活性化合物,从3种海草植物中获得3个新化合物和7个已知活性化合物,从6种海藻植物和1种共附生微生物中获得25个新化合物和8个已知活性化合物,主要涉及结构类型有萜类、生物碱、黄酮类、甾醇,多数具有良好的抗菌、抗氧化、抗肿瘤、抗炎、增强机体免疫力等功效。在此基础上,进一步提出了北部湾海洋植物研究方向及后续的研究建议。该综述为深入研究和开发利用北部湾海洋植物及其共附生微生物提供了参考。     

海洋微生物及海藻抗HIV天然产物研究进展

艾滋病是当今重大的公共卫生问题和社会问题。从天然资源寻找新抗HIV活性天然产物是新药发现的重要途径。综述了来源于海洋微生物、海藻具抗HIV活性的天然产物以及抗H1V活性天然产物筛选方法和靶点。     

海洋微生物及海藻抗HIV天然产物研究进展*

艾滋病是当今重大的公共卫生问题和社会问题。从天然资源寻找新抗HIV活性天然产物是新药发现的重要途径。综述了来源于海洋微生物、海藻具抗HIV活性的天然产物以及抗HIV活性天然产物筛选方法和靶点。     

海洋曲霉来源的新天然产物

海洋真菌由于其遗传背景复杂、代谢产物种类多且产量高,已成为海洋微生物新天然产物的主要来源,从我们对2010–2013年初的海洋微生物来源新天然产物的统计来看,研究最多的是曲霉属(Aspergillus)真菌,占海洋真菌来源新天然产物的31%。本文从菌株来源、化合物结构及其生物活性等方面,综述了自1992年第一个海洋曲霉天然产物到2014年8月已报道的共512个海洋曲霉来源的新天然产物。这些海洋天然产物具有丰富的化学多样性,且36%的化合物表现出细胞毒、抑菌、抗氧化和抗寄生虫等生物活性;含氮化合物是其主要的结构类型、约占曲霉源海洋天然产物总数的52%,也是出现活性化合物比例最高的结构类型、约40%的含氮化合物具有生物活性,其中脱氢二酮哌嗪生物碱halimide的化学衍生物plinabulin已结束II期临床研究,并于2015年第三季度开始在美国和中国进行III期临床研究,用于治疗转移性的晚期非小细胞肺癌。     

海洋沉积物来源链霉菌属次生代谢产物及其生物活性研究进展

海洋沉积物是营养较为丰富的微生物栖息地,近年来从海洋沉积物中分离培养出了大量海洋链霉菌,从中还发现了一些新的属种。人们已从海洋沉积物来源链霉菌属中发现了许多具有药用价值的活性化合物,有力推动了海洋天然产物化学的发展,并为新药研发提供基础。本文就海洋沉积物来源链霉菌属次生代谢产物的结构类型及其生物活性进行简要综述。     

海洋微生物资源及其产生生物活性代谢产物的研究

海洋微生物,尤其海洋细菌以其分类的多样性和规模而言,作为生物活性物质产生菌的潜力是巨大的。海洋微生物研究依据分离菌的生境来源可分为海水、沉积物、共栖、共生和深海菌群。生境的不同,不但影响菌群的分布,而且影响微生物代谢产物的合成。从报道的研究结果看,沉积物细菌、共栖细菌和共生细菌是海洋微生物天然药物筛选的重要来源。目前海洋微生物生物活性代谢产物资源的研究仍主要限制在那些在“标准”条件下易于生长和培养的微生物类群。本文对海洋微生物资源产生的生物活性物质的研究进展进行了综述。     

海洋微生物生物活性物质的研究进展

海洋微生物是海洋生物的重要组成部分.研究结果表明,海洋微生物产生的生物活性物质种类丰富, 主要包括抗肿瘤抗病毒物质、抗生素、生物毒素、酶类、酶抑制剂、多糖、不饱和脂肪酸等等.对海洋细菌、海洋真菌和海洋放线菌所产生的抗菌活性物质和抗肿瘤活性物质进行了综述.     

海洋真菌活性代谢产物最新研究进展

海洋微生物因其特殊的生存环境而具有产生新型生物活性物质的巨大潜力.近年来,从海洋真菌中分离鉴定了许多结构新颖的次级代谢产物,这些化合物显示了良好的抗肿瘤、抗细菌或抗真菌等生物活性.本文对近两年来海洋真菌所产生的活性物质的研究进展进行综述,并对其发展进行展望.     

海洋环境中难培养微生物的寡营养培养

海洋中存在着丰富的微生物资源, 但迄今为止能够在实验室培养的微生物却不到1%, 而且能够通过培养得到的环境优势种更少, 这成为当代环境微生物学研究和海洋资源开发的最大障碍。过去十多年来, 通过不断改进培养方法和检测手段, 发明了许多新颖独特的技术, 提高了培养效率。特别是通过海洋微生物的寡营养培养技术, 分离并命名了一些难培养微生物, 给予人们极大的启发。海洋微生物资源的可持续性开发和利用, 是21世纪人类发展的重要方向, 是我们研究海洋微观世界的基础, 值得微生物学界同仁的共同关注。     

Bio-mining the microbial treasures of the ocean: new natural products

The biological resources of the oceans have been exploited since ancient human history, mainly by catching fish and harvesting algae. Research on natural products with special emphasis on marine animals and also algae during the last decades of the 20th century has revealed the importance of marine organisms as producers of substances useful for the treatment of human diseases. Though a large number of bioactive substances have been identified, some many years ago, only recently the first drugs from the oceans were approved. Quite astonishingly, the immense diversity of microbes in the marine environments and their almost untouched capacity to produce natural products and therefore the importance of microbes for marine biotechnology was realized on a broad basis by the scientific communities only recently. This has strengthened worldwide research activities dealing with the exploration of marine microorganisms for biotechnological applications, which comprise the production of bioactive compounds for pharmaceutical use, as well as the development of other valuable products, such as enzymes, nutraceuticals and cosmetics. While the focus in these fields was mainly on marine bacteria, also marine fungi now receive growing attention. Although culture-dependent studies continue to provide interesting new chemical structures with biological activities at a high rate and represent highly promising approaches for the search of new drugs, exploration and use of genomic and metagenomic resources are considered to further increase this potential. Many efforts are made for the sustainable exploration of marine microbial resources. Large culture collections specifically of marine bacteria and marine fungi are available. Compound libraries of marine natural products, even of highly purified substances, were established. The expectations into the commercial exploitation of marine microbial resources has given rise to numerous institutions worldwide, basic research facilities as well as companies. In Europe, recent activities have initiated a dynamic development in marine biotechnology, though concentrated efforts on marine natural product research are rare. One of these activities is represented by the Kieler Wirkstoff-Zentrum KiWiZ, which was founded in 2005 in Kiel (Germany).     

海洋微生物高通量培养方法和分选技术的研究进展

海洋环境中蕴含着丰富的微生物资源,其在生态系统中发挥着重要作用,与人类生活息息相关。但是迄今通过传统的培养方法可被培养分离的海洋微生物不到1%。本文论述了海洋微生物的重要性,大多数海洋微生物不可被培养的原因,以及高通量培养方法和分选技术的研究进展。随着研究的深入,将会有更加实用有效的高通量培养方法和分选技术出现。     

Phylogenetic diversity of culturable fungi associated with the Hawaiian Sponges Suberites zeteki and Gelliodes fibrosa

Sponges are well documented to harbor large amounts of microbes. Both culture-dependent and molecular approaches have revealed remarkable bacterial diversity in marine sponges. Fungi are commonly isolated from marine sponges, yet no reports on phylogenetic diversity of sponge-inhabiting fungi exist. In this report, we investigated the phylogenetic diversity of culturable fungi from the Hawaiian alien marine sponges Suberites zeteki and Gelliodes fibrosa. A total of 44 independent isolates were recovered from these two sponge species, representing 7 orders and 22 genera of Ascomycota. The majority (58%) of fungal isolates from S. zeteki resided in the Pleosporales group, while the predominant isolates (52%) from G. fibrosa were members of the Hypocreales group. Though differing in fungal species composition and structure, culturable communities of these two sponges displayed similar phylogenetic diversity. At the genus level, only two genera Penicillium and Trichoderma in the Eurotiales and Hypocreales orders, respectively, were present in both sponge species. The other genera of the fungal isolates were associated with either S. zeteki or G. fibrosa. Some of these fungal genera had been isolated from sponges collected in other marine habitats, but more than half of these genera were identified for the first time in these two marine sponges. Overall, the diversity of culturable fungal communities from these two sponge species is much higher than that observed in studies of marine sponges from other areas. This is the first report of phylogenetic diversity of marine sponge-associated fungi and adds one more dimension to our current understanding of the phylogenetic diversity of sponge-symbiotic microbes.     

Pharmaceutically active secondary metabolites of marine actinobacteria

Marine actinobacteria are one of the most efficient groups of secondary metabolite producers and are very important from an industrial point of view. Many representatives of the order Actinomycetales are prolific producers of thousands of biologically active secondary metabolites. Actinobacteria from terrestrial sources have been studied and screened since the 1950s, for many important antibiotics, anticancer, antitumor and immunosuppressive agents. However, frequent rediscovery of the same compounds from the terrestrial actinobacteria has made them less attractive for screening programs in the recent years. At the same time, actinobacteria isolated from the marine environment have currently received considerable attention due to the structural diversity and unique biological activities of their secondary metabolites. They are efficient producers of new secondary metabolites that show a range of biological activities including antibacterial, antifungal, anticancer, antitumor, cytotoxic, cytostatic, anti-inflammatory, anti-parasitic, anti-malaria, antiviral, antioxidant, anti-angiogenesis, etc. In this review, an evaluation is made on the current status of research on marine actinobacteria yielding pharmaceutically active secondary metabolites. Bioactive compounds from marine actinobacteria possess distinct chemical structures that may form the basis for synthesis of new drugs that could be used to combat resistant pathogens. With the increasing advancement in science and technology, there would be a greater demand for new bioactive compounds synthesized by actinobacteria from various marine sources in future.     

Marine lysozyme from a marine bacterium that inhibits angiogenesis and tumor growth

Recent studies suggest that lysozyme, rich in hen egg, has an antitumor function. In the present study, we investigated the antitumor and antiangiogenesis effects of a newly isolated marine lysozyme both in vitro and in vivo. First, we showed that this marine-derived lysozyme specifically inhibits the proliferation of endothelial cells (ECV304) in a dose-dependent manner with no cytotoxicity (IC₅₀ = 3.64 μM). Second, we showed that this marine lysozyme directly suppresses neovascularization in chicken embryos using chorioallantoic membrane assay. Third, we demonstrated that this marine lysozyme markedly inhibits tumor growth in mice bearing either sarcoma 180 or hepatoma 22. Unexpectedly, hen egg lysozyme has no effects on the proliferation of endothelial cells in vitro or neovascularization in chicken embryos or tumor growth in nude mice at the same dosage range. Taken together, our studies clearly show that the newly identified marine lysozyme is a potent antitumor molecule, which may inhibit tumor growth and inhibit angiogenesis. We believe that this marine lysozyme may have a therapeutic value in antitumor drug development.     

海洋生物资源开发研究概况与展望

对各类主要的海洋生物资源开发研究作了简洁概述,从海洋生物体内获取的各种活性物质,除可研究海洋药物外,还可开发海洋生物功能性保健品,海洋生物化工产品等;此外,尚可利用其特异的化学结构作为先导物,设计合成治疗疑难病的创新药物。可以预言,２１世纪将是人类研究、开发、利用海洋生物资源的黄金时代     

海洋生物资源与可持续利用对策研究

海洋生态环境恶化和不合理的开发利用,使我国海洋生物资源严重衰退。开展海洋生物资源学相关基础研究,重点进行海洋环境与生物资源保护,运用海洋生物技术等高新技术,科学、合理地开发利用生物资源,是实现海洋生物资源可持续利用和长久发展的可行策略。着重分析了海洋生物资源状况及其生态环境问题,提出了未来我国海洋生物资源的发展对策。     

海洋微生物生物活性物质研究

海洋微生物以其分类的多样性和遗传背景的特征而具有产生新型生物活性物质的巨大潜力,本文对海洋微生物产生的生物活性物质的研究进展进行了综述,从报道的研究结果看,占海洋微生物主导地位的海洋细菌产生的活性物质种类最为丰富;海洋真菌和海洋放射线菌虽非海洋微生物中的主要菌群,但其产生新型生物活性物质的潜能不可低估。此外,目前研究主要局限于那些在常规条件下易于培养的微生物类群,今后的之一是对于非可培养海洋微生物产生的生物活性物质的探索,我国应充分利用国内海洋微生物资源优势加强这一领域的研究。     

不同生境具有抗肿瘤活性的海洋真菌筛选

目的:为了测定海口沿海海域不同生境的海洋真菌抗肿瘤状况。方法:我们从海口西海岸沿线、南渡江入海口处以及演丰红树林三个不同生境分离到162株海洋真菌,通过MTT比色法测定海洋真菌代谢产物对黑色素瘤B16的抑制活性。结果:其中75.93%的海洋真菌代谢产物对B16细胞增殖有不同的抑制作用,来自西海岸沿线生境的真菌有77.36%具有抑制B16生长作用,来自入海口生境的真菌为77.27%,来自红树林的真菌为70.58%,并且不同生境的真菌代谢物的细胞毒性强弱也有明显的区别。结论:不同生境的真菌具有不同的抗肿瘤作用,筛选具有某种活性海洋真菌菌株时,可以选择容易产某种活性成分的目的生境。